Disease-A-Month
Volume 55, Issue 9 , Pages 532-585 , September 2009

Syncope

References 

  1. Brignole M, Alboni P, Benditt D, et al. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J. 2001;22:1256–1306
  2. Brignole M, Alboni P, Benditt D, et al. Guidelines on management (diagnosis and treatment) of syncope—Update 2004. Europace. 2004;6:467–537
  3. Benditt DG, Brignole M. Syncope: Is a diagnosis a diagnosis?. J Am Coll Cardiol. 2003;41:791–794
  4. Posner JB, Plum F. R2 Library. In: Plum and Posner's Diagnosis of Stupor and Coma. Oxford: Oxford University Press; 2007;p. 71
  5. Thijs RD, Benditt DG, Mathias CJ, et al. Unconscious confusion—A literature search for definitions of syncope and related disorders. Clin Auton Res. 2005;15:35–39
  6. Strickberger SA, Benson DW, Biaggioni I, et al. AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association councils on clinical cardiology, cardiovascular nursing, cardiovascular disease in the young, and stroke, and the quality of care and outcomes research interdisciplinary working group; and the American College of Cardiology foundation: in collaboration with the Heart Rhythm Society: Endorsed by the American autonomic society. Circulation. 2006;113:316–327
  7. Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347:878–885
  8. Chen-Scarabelli C, Scarabelli TM. Neurocardiogenic syncope. BMJ. 2004;329:336–341
  9. Grubb BP. Neurocardiogenic syncope and related disorders of orthostatic intolerance. Circulation. 2005;111:2997–3006
  10. Mathias CJ, Bannister R. Clinical features and evaluation of the primary chronic autonomic failure syndromes. In:  Bannister R,  Mathias CJ editor. Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. 4th ed.. New York, Oxford: Oxford University Press; 1999;p. 562
  11. Lempert T, Bauer M, Schmidt D. Syncope: A videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol. 1994;36:233–237
  12. Stevens DL, Matthews WB. Cryptogenic drop attacks: An affliction of women. Br Med J. 1973;1:439–442
  13. Alboni P, Brignole M, Menozzi C, et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 2001;37:1921–1928
  14. Colman N, Nahm K, van Dijk JG, et al. Diagnostic value of history taking in reflex syncope. Clin Auton Res. 2004;14(suppl 1):37–44
  15. Sheldon R, Serletis A. Epidemiologic aspects of transient loss of consciousness. In:  Benditt DG,  Brignole M,  Raviele A, et al. editor. Syncope and Transient Loss of Consciousness: Multidisciplinary Management. Oxford: Blackwell Futura; 2007;p. 194
  16. Savage DD, Corwin L, McGee DL, et al. Epidemiologic features of isolated syncope: The Framingham study. Stroke. 1985;16:626–629
  17. Chen LY, Shen WK, Mahoney DW, et al. Prevalence of syncope in a population aged more than 45 years. Am J Med. 2006;119:1088e1-e7
  18. Ganzeboom KS, Colman N, Reitsma JB, et al. Prevalence and triggers of syncope in medical students. Am J Cardiol. 2003;91:1006–1008A8
  19. Serletis A, Rose S, Sheldon AG, et al. Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J. 2006;27:1965–1970
  20. Lipsitz LA, Wei JY, Rowe JW. Syncope in an elderly, institutionalised population: Prevalence, incidence, and associated risk. Q J Med. 1985;55:45–54
  21. van Lieshout JJ, Wieling W, Karemaker JM, et al. The vasovagal response. Clin Sci Lond. 1991;81:575–586
  22. Wieling W. Maintaining blood pressure whilst upright: Physiology and potential for disturbances to cause syncope. In:  Benditt DG editors. 2nd ed. The Evaluation and Treatment of Syncope: A Handbook for Clinical Practice. vol 301:Malden, MA: Blackwell Publishing; 2006;European Society of Cardiology, editors
  23. Abi-Samra F, Maloney JD, Fouad-Tarazi FM, et al. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. Pacing Clin Electrophysiol. 1988;11:1202–1214
  24. Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 1989;320:346–351
  25. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope; American College of Cardiology. J Am Coll Cardiol. 1996;28:263–275
  26. Fitzpatrick AP, Theodorakis G, Vardas P, et al. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol. 1991;17:125–130
  27. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: A comprehensive literature review. Am J Med. 1994;97:78–88
  28. Kenny RA, Ingram A, Bayliss J, et al. Head-up tilt: A useful test for investigating unexplained syncope. Lancet. 1986;1:1352–1355
  29. Sutton R, Petersen ME. The clinical spectrum of neurocardiogenic syncope. J Cardiovasc Electrophysiol. 1995;6:569–576
  30. Brignole M, Menozzi C, Gianfranchi L, et al. Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome. Am J Cardiol. 1991;68:1032–1036
  31. Morley CA, Sutton R. Carotid sinus syncope. Int J Cardiol. 1984;6:287–293
  32. Parry SW, Richardson DA, O'Shea D, et al. Diagnosis of carotid sinus hypersensitivity in older adults: Carotid sinus massage in the upright position is essential. Heart. 2000;83:22–23
  33. Benditt DG, Samniah N, Pham S, et al. Effect of cough on heart rate and blood pressure in patients with “cough syncope.”. Heart Rhythm. 2005;2:807–813
  34. Bannister R. Chronic autonomic failure with postural hypotension. Lancet. 1979;2:404–406
  35. Hopkins A, Neville B, Bannister R. Autonomic neuropathy of acute onset. Lancet. 1974;1:769–771
  36. Low PA, Opfer-Gehrking TL, McPhee BR, et al. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc. 1995;70:617–622
  37. Koike Y, Takahashi A. Autonomic dysfunction in Parkinson's disease. Eur Neurol. 1997;38(suppl 2):8–12
  38. Brignole M, Menozzi C, Moya A, et al. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation. 2001;104:2045–2050
  39. Brignole M, Sutton R, Menozzi C, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J. 2006;27:1085–1092
  40. Menozzi C, Brignole M, Garcia-Civera R, et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation. 2002;105:2741–2745
  41. Moya A. Cardiac arrhythmias and conduction system disease as a primary cause of syncope. In:  Benditt DG editors. The Evaluation and Treatment of Syncope: A Handbook for Clinical Practice. 2nd ed.. Malden, MA: Blackwell Publishing; 2006;p. 301–305European Society of Cardiology, editors
  42. Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001;104:1261–1267
  43. Benditt DG, Gornick CC, Dunbar D, et al. Indications for electrophysiologic testing in the diagnosis and assessment of sinus node dysfunction. Circulation. 1987;75:93–102III
  44. Kaul U, Dev V, Narula J, et al. Evaluation of patients with bundle branch block and “unexplained” syncope: A study based on comprehensive electrophysiologic testing and ajmaline stress. Pacing Clin Electrophysiol. 1988;11:289–297
  45. McAnulty JH, Rahimtoola SH, Murphy E, et al. Natural history of “high-risk” bundle-branch block: Final report of a prospective study. N Engl J Med. 1982;307:137–143
  46. Morady F, Higgins J, Peters RW, et al. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol. 1984;54:587–591
  47. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350–e408
  48. Dhingra RC, Palileo E, Strasberg B, et al. Significance of the HV interval in 517 patients with chronic bifascicular block. Circulation. 1981;64:1265–1271
  49. Scheinman MM, Peters RW, Suavé MJ, et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol. 1982;50:1316–1322
  50. Camm AJ, Lau C-P. Syncope of undetermined origin: Diagnosis and management. Prog Cardiol. 1988;1:139–156
  51. Leitch JW, Klein GJ, Yee R, et al. Syncope associated with supraventricular tachycardia (An expression of tachycardia rate or vasomotor response?). Circulation. 1992;85:1064–1071
  52. Olshansky B, Poole JE, Johnson G, et al. Syncope predicts the outcome of cardiomyopathy patients: Analysis of the SCD-HeFT study. J Am Coll Cardiol. 2008;51:1277–1282
  53. Dixon MS, Thomas P, Sheridan DJ. Syncope as the presentation of unstable angina. Int J Cardiol. 1988;19:125–129
  54. Pathy MS. Clinical presentation of myocardial infarction in the elderly. Br Heart J. 1967;29:190–199
  55. Mark AL. The Bezold–Jarisch reflex revisited: Clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol. 1983;1:90–102
  56. Prasad K, Williams L, Campbell R, et al. Episodic syncope in hypertrophic cardiomyopathy: Evidence for inappropriate vasodilation. Heart. 2008;94:1312–1317
  57. Hadjipetrou P, Cox S, Piemonte T, et al. Percutaneous revascularization of atherosclerotic obstruction of aortic arch vessels. J Am Coll Cardiol. 1999;33:1238–1245
  58. Shechter A, Stewart WF, Silberstein SD, et al. Migraine and autonomic nervous system function: A population-based, case-control study. Neurology. 2002;58:422–427
  59. Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000;55:754–762
  60. Thijs RD, Kruit MC, van Buchem MA, et al. Syncope in migraine: The population-based CAMERA study. Neurology. 2006;66:1034–1037
  61. Zaidi A, Clough P, Cooper P, et al. Misdiagnosis of epilepsy: Many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol. 2000;36:181–184
  62. Huff JS, Decker WW, Quinn JV, et al. Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope. Ann Emerg Med. 2007;49:431–444
  63. Shen WK, Decker WW, Smars PA, et al. Syncope evaluation in the emergency department study (SEEDS): A multidisciplinary approach to syncope management. Circulation. 2004;110:3636–3645
  64. Ammirati F, Colivicchi F, Minardi G, et al. The management of syncope in the hospital: The OESIL study (osservatorio epidemiologico della sincope Nel Lazio). G Ital Cardiol. 1999;29:533–539
  65. Colivicchi F, Ammirati F, Melina D, et al. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: The OESIL risk score. Eur Heart J. 2003;24:811–819
  66. Quinn JV, Stiell IG, McDermott DA, et al. Derivation of the San Francisco syncope rule to predict patients with short-term serious outcomes. Ann Emerg Med. 2004;43:224–232
  67. Reed MJ, Newby DE, Coull AJ, et al. The risk stratification of syncope in the emergency department (ROSE) pilot study: A comparison of existing syncope guidelines. Emerg Med J. 2007;24:270–275
  68. Bartoletti A, Fabiani P, Adriani P, et al. Hospital admission of patients referred to the emergency department for syncope: A single-hospital prospective study based on the application of the European Society of Cardiology guidelines on syncope. Eur Heart J. 2006;27:83–88
  69. Brignole M, Ungar A, Bartoletti A, et al. Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals. Europace. 2006;8:644–650
  70. Sakaguchi S, Shultz JJ, Remole SC, et al. Syncope associated with exercise, a manifestation of neurally mediated syncope. Am J Cardiol. 1995;75:476–481
  71. Calkins H, Shyr Y, Frumin H, et al. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med. 1995;98:365–373
  72. Kapoor WN, Brant N. Evaluation of syncope by upright tilt testing with isoproterenol (A nonspecific test). Ann Intern Med. 1992;116:358–363
  73. Sheldon R, Killam S. Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol. 1992;19:773–779
  74. Flammang D, Church T, Waynberger M, et al. Can adenosine 5′-triphosphate be used to select treatment in severe vasovagal syndrome?. Circulation. 1997;96:1201–1208
  75. Brignole M, Sutton R, Menozzi C, et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J. 2006;27:2232–2239
  76. Brignole M, Croci F, Menozzi C, et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol. 2002;40:2053–2059
  77. Krediet CT, van Dijk N, Linzer M, et al. Management of vasovagal syncope: Controlling or aborting faints by leg crossing and muscle tensing. Circulation. 2002;106:1684–1689
  78. Krediet CT, de Bruin IG, Ganzeboom KS, et al. Leg crossing, muscle tensing, squatting, and the crash position are effective against vasovagal reactions solely through increases in cardiac output. J Appl Physiol. 2005;99:1697–1703
  79. van Dijk N, Quartieri F, Blanc JJ, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: The physical counterpressure manœuvers trial (PC-trial). J Am Coll Cardiol. 2006;48:1652–1657
  80. Ector H, Reybrouck T, Heidbuchel H, et al. Tilt training: A new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance. Pacing Clin Electrophysiol. 1998;21:193–196
  81. Di Girolamo E, Di Iorio C, Leonzio L, et al. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study. Circulation. 1999;100:1798–1801
  82. Kinay O, Yazici M, Nazli C, et al. Tilt training for recurrent neurocardiogenic syncope: Effectiveness, patient compliance, and scheduling the frequency of training sessions. Jpn Heart J. 2004;45:833–843
  83. Reybrouck T, Heidbuchel H, Van De Werf F, et al. Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol. 2002;25:1441–1446
  84. Gurevitz O, Barsheshet A, Bar-Lev D, et al. Tilt training: Does it have a role in preventing vasovagal syncope?. Pacing Clin Electrophysiol. 2007;30:1499–1505
  85. On YK, Park J, Huh J, et al. Is home orthostatic self-training effective in preventing neurally mediated syncope?. Pacing Clin Electrophysiol. 2007;30:638–643
  86. Grubb BP, Samoil D, Kosinski D, et al. The use of serotonin reuptake inhibitors for the treatment of recurrent syncope due to carotid sinus hypersensitivity unresponsive to dual chamber cardiac pacing. Pacing Clin Electrophysiol. 1994;17:1434–1436
  87. Grubb BP, Wolfe DA, Samoil D, et al. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. Pacing Clin Electrophysiol. 1993;16:458–464
  88. Sra J, Maglio C, Biehl M, et al. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy. J Cardiovasc Electrophysiol. 1997;8:42–46
  89. Kenny RA, Richardson DA, Steen N, et al. Carotid sinus syndrome: A modifiable risk factor for nonaccidental falls in older adults (safe PACE). J Am Coll Cardiol. 2001;38:1491–1496
  90. Epstein AE, Baessler CA, Curtis AB, et al. Addendum to “Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations: A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”: Public safety issues in patients with implantable defibrillators: A scientific statement from the American Heart Association and the Heart Rhythm Society. Circulation. 2007;115:1170–1176
  91. Young TM, Mathias CJ. The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: Multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry. 2004;75:1737–1741
  92. Laughlin JC, Kowey PR. Dronedarone. J Cardiovasc Electrophysiol. 2008;19(11):1220–1226
  93. Naccarelli GV, Wolbrette DL, Khan M. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: Comparative efficacy and results of trials. 2008 Nov;19(11):1220-6 Am J Cardiol. 2003;91:15D–26D
  94. Ozcan C, Jahangir A, Friedman PA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med. 2001;344:1043–1051

PII: S0011-5029(09)00051-0

doi: 10.1016/j.disamonth.2009.04.004

Disease-A-Month
Volume 55, Issue 9 , Pages 532-585 , September 2009

Article Tools

* Image Usage & Resolution